ACTRN12618001250224已完成未知
Validating Fatigue Crash Risk and Ocular Measures of Alertness in Drivers with Sleep Apnoea.
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 21 Years 至 80 Years（—）
- 性别
- All
入选标准
- •All participants
- •Aged 21-80
- •Non-smoker
- •Have held a current driver license for at least 3 years
- •Have driven an average of 5000 km or more per year or drive more than 4 hours a week
- •Sleep Apnoea Participants:
- •- Have moderate to severe sleep apnoea (Apnea-Hypopnea Index > 15 events per hour)
排除标准
- •Conditions that contraindicate driving (e.g. epilepsy, etc)
- •Regular use of benzodiazepine and analgesic medication
- •Current night shift worker
- •Impaired vision that cannot be corrected with glasses
- •Difficulty understanding, reading and writing in English
- •Pregnant women
- •Sleep apnoea participant specific exclusion criteria -
- •Currently treated for OSA
研究者
相似试验
已完成
不适用
Objective Measurement of Ocular Fatigue Associated With Persistent Use of SmartphoneDiseases of the eye and adnexaKCT0004812Chung-Ang Univerisity Hospital26
已完成
不适用
Verification of eye fatigue suppression effect by ingesting test foods. A placebo-controlled, Simple Randomization, double blind, cross over trial.healthy adultJPRN-UMIN000037406School of Allied Health Sciences, Kitasato University50
尚未招募
不适用
Verification of eye fatigue suppression effect by ingesting test foods. A placebo-controlled, Simple Randomization, open, cross over trial.healthy adultJPRN-UMIN000031400otte Co., Ltd.10
已完成
不适用
Study of ocular safety for 222 nm UVC room disinfection lampJPRN-UMIN000042867Shimane University5
进行中（未招募）
不适用
Evaluation of Safety and Efficacy on Visual Acuity Outcome and Choroidal Neovascularization of Intravitreal Somministration of Bevacizumab Avastin, Roche, United Kingdom in patients with Subfoveal Choroidal Neovascularization due to Age Related Macular Degeneration - NDSubfoveal Choroidal Neovascularization due to Age Related Macular Degeneration who did not respond to currently available treatmentsMedDRA version: 6.1Level: PTClassification code 10060823EUCTR2006-002424-42-ITOSPEDALE SACRO CUORE-DON CALABRIA150